161 related articles for article (PubMed ID: 24566406)
21. 131I-SPECT/CT found an ovarian metastasis covered by iliac metastasis on 131I whole-body scan in a patient with papillary thyroid carcinoma.
Xu YH; Huang XM; Song HJ; Qiu ZL; Luo QY
Clin Nucl Med; 2011 May; 36(5):363-4. PubMed ID: 21467854
[No Abstract] [Full Text] [Related]
22. Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.
Naddaf SY; Syed GM; Hadb A; Al-Thaqfi S
Clin Nucl Med; 2016 Sep; 41(9):693-4. PubMed ID: 27405041
[TBL] [Abstract][Full Text] [Related]
23. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
24. 123I accumulation in thoracic neoesophagus masking residual papillary thyroid cancer.
Jackson T; Sabbah N; Iagaru A
Clin Nucl Med; 2015 Feb; 40(2):e150-1. PubMed ID: 24999691
[TBL] [Abstract][Full Text] [Related]
25. Detection of papillary thyroid cancer brain metastasis with FDG-PET/CT.
Rini JN; Nguyen VT; Ben-Levi E; Naidich JJ; Yi Li J; Palestro CJ
Clin Nucl Med; 2010 May; 35(5):357-9. PubMed ID: 20395715
[No Abstract] [Full Text] [Related]
26. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation.
Borde C; Basu S; Kand P; Arya S; Shet T
Hell J Nucl Med; 2011; 14(1):72-3. PubMed ID: 21512673
[No Abstract] [Full Text] [Related]
27. Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
Byun BH; Jeong UG; Hong SP; Min JJ; Chong A; Song HC; Bom HS
Ann Nucl Med; 2012 Jul; 26(6):471-7. PubMed ID: 22467230
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases with exceptional features from papillary thyroid carcinoma: report of three cases.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2011; 14(1):56-9. PubMed ID: 21512667
[TBL] [Abstract][Full Text] [Related]
30. An intrapericardial ectopic thyroid mimicking metastasis in a patient with papillary thyroid cancer: Localization, differential diagnosis by
Park SH; Seo M; Park TY; Nam-Goong S
Hell J Nucl Med; 2016; 19(3):272-274. PubMed ID: 27824968
[TBL] [Abstract][Full Text] [Related]
31. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
32. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
Ranade R; Kand P; Basu S
Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373
[TBL] [Abstract][Full Text] [Related]
33. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
34. Unusual case of isolated parasellar metastasis from carcinoma of thyroid.
Malhotra G; Asopa RV; Sridhar E
Clin Nucl Med; 2013 Feb; 38(2):145-8. PubMed ID: 23334134
[TBL] [Abstract][Full Text] [Related]
35. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
Ma C; Wang X; Shao M; Zhao L; Jiawei X; Wu Z; Wang H
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):220-7. PubMed ID: 24844253
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
Wang Y; Jiang L; Zhang X; Xu Y; Liu B
Clin Nucl Med; 2022 Jun; 47(6):541-542. PubMed ID: 35025802
[TBL] [Abstract][Full Text] [Related]
38. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
[TBL] [Abstract][Full Text] [Related]
39. Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Lin YS; Liang ZY; Qiu LH; Cheng X
Chin Med J (Engl); 2012 Jan; 125(1):153-6. PubMed ID: 22340484
[TBL] [Abstract][Full Text] [Related]
40. Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Giovanella L; Ceriani L; De Palma D; Suriano S; Castellani M; Verburg FA
Head Neck; 2012 May; 34(5):626-31. PubMed ID: 21850699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
